Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practiceInés Suárez‐García, Julia Portilla, Mar Vera García et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 36
Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapyJose-Ramon Blanco, CoRIS Cohort, Miguel Torralba et al.|PLoS ONE|2026Cited by 0